Peter J. Adamson

759 total citations
16 papers, 570 citations indexed

About

Peter J. Adamson is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Peter J. Adamson has authored 16 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Peter J. Adamson's work include Lymphoma Diagnosis and Treatment (4 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Glutathione Transferases and Polymorphisms (2 papers). Peter J. Adamson is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Glutathione Transferases and Polymorphisms (2 papers). Peter J. Adamson collaborates with scholars based in United Kingdom, United States and Norway. Peter J. Adamson's co-authors include Eve Roman, Gareth J. Morgan, Cemal Cingi, Burak Ömür Çakır, Christine F. Skibola, Martyn T. Smith, James M. Allan, Tracy Lightfoot, Eleanor V. Willett and Danica R. Skibola and has published in prestigious journals such as Blood, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Peter J. Adamson

15 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Adamson United Kingdom 12 235 188 120 107 80 16 570
Ronald Honchel United States 11 249 1.1× 141 0.8× 297 2.5× 127 1.2× 138 1.7× 15 720
David J. Hunter United States 10 597 2.5× 125 0.7× 45 0.4× 67 0.6× 171 2.1× 12 982
H. Hassan Egypt 10 147 0.6× 138 0.7× 102 0.8× 59 0.6× 19 0.2× 22 547
Bożena Chodynicka Poland 14 139 0.6× 86 0.5× 113 0.9× 29 0.3× 31 0.4× 49 608
Lakhvir K. Assi United Kingdom 12 337 1.4× 62 0.3× 78 0.7× 57 0.5× 19 0.2× 17 737
Marilena Fazi Italy 15 230 1.0× 120 0.6× 104 0.9× 197 1.8× 19 0.2× 36 703
Braulio Martínez‐Benítez Mexico 15 119 0.5× 135 0.7× 36 0.3× 199 1.9× 20 0.3× 72 651
Anna Maria Berghella Italy 15 142 0.6× 298 1.6× 128 1.1× 52 0.5× 21 0.3× 38 714
Ashley Gilmour United Kingdom 7 339 1.4× 81 0.4× 50 0.4× 41 0.4× 29 0.4× 7 716
Qun Liu China 15 234 1.0× 161 0.9× 101 0.8× 60 0.6× 58 0.7× 41 687

Countries citing papers authored by Peter J. Adamson

Since Specialization
Citations

This map shows the geographic impact of Peter J. Adamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Adamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Adamson more than expected).

Fields of papers citing papers by Peter J. Adamson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Adamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Adamson. The network helps show where Peter J. Adamson may publish in the future.

Co-authorship network of co-authors of Peter J. Adamson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Adamson. A scholar is included among the top collaborators of Peter J. Adamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Adamson. Peter J. Adamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Adamson, Peter J., et al.. (2020). The Safety of Foot and Ankle Surgical Procedures at an Ambulatory Surgery Center. Foot & Ankle Orthopaedics. 5(4).
2.
Çakır, Burak Ömür, Peter J. Adamson, & Cemal Cingi. (2012). Epidemiology and Economic Burden of Nonmelanoma Skin Cancer. Facial Plastic Surgery Clinics of North America. 20(4). 419–422. 101 indexed citations
3.
Worrillow, Lisa, Eve Roman, Peter J. Adamson, et al.. (2009). Polymorphisms in the nucleotide excision repair gene ERCC2/XPD and risk of non-Hodgkin lymphoma. Cancer Epidemiology. 33(3-4). 257–260. 18 indexed citations
4.
Mensah, Fiona, Mark S. Gilthorpe, Leigh Keen, et al.. (2007). Haplotype uncertainty in association studies. Genetic Epidemiology. 31(4). 348–357. 12 indexed citations
5.
Adamson, Peter J., Freddie Bray, Adele Seniori Costantini, et al.. (2006). Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. European Journal of Cancer. 43(2). 391–401. 59 indexed citations
6.
Rollinson, Sara, Alexandra Smith, James M. Allan, et al.. (2006). RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia. Leukemia Research. 31(2). 169–174. 28 indexed citations
7.
Lightfoot, Tracy, Christine F. Skibola, A. G. Smith, et al.. (2006). Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma.. PubMed. 91(9). 1222–7. 76 indexed citations
8.
Skibola, Christine F., Tracy Lightfoot, Luz Agana, et al.. (2005). Polymorphisms in cytochrome P450 17A1 and risk of non‐Hodgkin lymphoma. British Journal of Haematology. 129(5). 618–621. 11 indexed citations
9.
Morgan, Gareth J., Peter J. Adamson, Fiona Mensah, et al.. (2005). Haplotypes in the tumour necrosis factor region and myeloma. British Journal of Haematology. 129(3). 358–365. 37 indexed citations
10.
Willett, Eleanor V., Christine F. Skibola, Peter J. Adamson, et al.. (2005). Non-Hodgkin's lymphoma, obesity and energy homeostasis polymorphisms. British Journal of Cancer. 93(7). 811–816. 65 indexed citations
11.
Lightfoot, Tracy, Christine F. Skibola, Eleanor V. Willett, et al.. (2005). Risk of Non–Hodgkin Lymphoma Associated with Polymorphisms in Folate-Metabolizing Genes. Cancer Epidemiology Biomarkers & Prevention. 14(12). 2999–3003. 69 indexed citations
12.
Adamson, Peter J. & Richard McNally. (2005). Hodgkin's disease.. 1 indexed citations
13.
Hank, Jacquelyn A., Mark R. Albertini, Alexander Sternberg, et al.. (2004). A Phase I Trial of Immunocytokine HU14.18-IL2 in Children with Recurrent or Refractory Neuroblastoma and Other GD2 Positive Malignancies: A Study of the Children's Oncology Group. Journal of Immunotherapy. 27(6). S55–S56. 3 indexed citations
14.
Mikeljevic, J Stefoski, et al.. (2003). How complete has skin cancer registration been in the UK? A study from Yorkshire. European Journal of Cancer Prevention. 12(2). 125–133. 15 indexed citations
15.
Dasgupta, Ranjit, Peter J. Adamson, Faith E. Davies, et al.. (2003). Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma. Blood. 102(7). 2345–2350. 73 indexed citations
16.
Dasgupta, Ranjit, et al.. (2003). No effect of P2X7 receptor polymorphism on risk of CLL or on outcome from therapy in the UK population. 1. 26. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026